News Digest / Ticker: PTIX

Ticker: PTIX

05:12pm, Wednesday, Sep 10, 2025

Protagenic completes Phytanix merger, raises cash but posts $5M loss, approves $8M cuts

Protagenic Therapeutics, Inc. (NASDAQ: PTIX) - Quick company update What's happening: the company completed a reverse-merger/acquisition of Phytanix Bio (effective May 15, 2025), issued preferred and common shares, added five preclinical programs and related IP, raised cash via warrant exercises...

04:04pm, Tuesday, May 13, 2025

Protagenic Therapeutics Reports Q1 2025 Loss Reduction Amid Biopharma Challenges and Opportunities

Protagenic Therapeutics, Inc. (NASDAQ: PTIX) has recently released its Q1 2025 earnings report, revealing both challenges and opportunities as the company continues its path in the biopharmaceutical sector, focusing on therapies for neuropsychiatric conditions. Key Points from Q1 2025 Financial P...